{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:54:01Z","timestamp":1771487641593,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":3099,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.fertnstert.2013.08.007","type":"journal-article","created":{"date-parts":[[2013,9,12]],"date-time":"2013-09-12T15:26:27Z","timestamp":1378999587000},"page":"1590-1593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Does methotrexate administration for\u00a0ectopic pregnancy after in\u00a0vitro fertilization impact ovarian reserve or ovarian responsiveness?"],"prefix":"10.1016","volume":"100","author":[{"given":"Christina E.","family":"Boots","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Gustofson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eve C.","family":"Feinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2013.08.007_bib1","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/01.AOG.0000158860.26939.2d","article-title":"Ectopic pregnancy rate and treatment utilization in a large managed care organization","volume":"105","author":"Van Den Eeden","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2013.08.007_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/01.AOG.0000194207.06554.5b","article-title":"Outcomes from assisted reproductive technology","volume":"107","author":"Van Voorhis","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2013.08.007_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1021106032198","article-title":"Surveillance in a time of changing health care practices: estimating ectopic pregnancy incidence in the United States","volume":"6","author":"Zane","year":"2002","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.fertnstert.2013.08.007_bib4","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0015-0282(02)04198-5","article-title":"Assisted reproductive technology in the United States: 1999 results generated from the American Society for Reproductive Medicine\/Society for Assisted Reproductive Technology Registry","volume":"78","author":"American Society for Reproductive Medicine","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.08.007_bib5","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM199310143291608","article-title":"Ectopic pregnancy","volume":"329","author":"Carson","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2013.08.007_bib6","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1056\/NEJM199912233412604","article-title":"Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies","volume":"341","author":"Lipscomb","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2013.08.007_bib7","first-page":"749","article-title":"Methotrexate treatment of unruptured ectopic pregnancy: a report of 100 cases","volume":"77","author":"Stovall","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2013.08.007_bib8","first-page":"778","article-title":"The medical management of\u00a0ectopic pregnancy: a meta-analysis comparing \u201csingle dose\u201d and \u201cmultidose\u201d regimens","volume":"101","author":"Barnhart","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2013.08.007_bib9","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/0002-9378(90)90928-Z","article-title":"Reproductive performance after methotrexate treatment of ectopic pregnancy","volume":"162","author":"Stovall","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2013.08.007_bib10","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1634\/theoncologist.12-9-1044","article-title":"How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embryo, oocytes, or ovaries","volume":"12","author":"Blumenfeld","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.fertnstert.2013.08.007_bib11","first-page":"754","article-title":"Single-dose methotrexate for treatment of ectopic pregnancy","volume":"77","author":"Stovall","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2013.08.007_bib12","first-page":"131","article-title":"Reproductive performance after ectopic pregnancy","volume":"25","author":"Buster","year":"2007","journal-title":"Sem\u00a0Reprod Med"},{"key":"10.1016\/j.fertnstert.2013.08.007_bib13","first-page":"28","article-title":"Reproductive outcome after methotrexate treatment of tubal pregnancies","volume":"43","author":"Keefe","year":"1998","journal-title":"J Reprod Med"},{"key":"10.1016\/j.fertnstert.2013.08.007_bib14","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.fertnstert.2007.01.064","article-title":"Does methotrexate treatment for ectopic pregnancy influence the patient's performance during a subsequent in\u00a0vitro fertilization\/embryo transfer cycle?","volume":"88","author":"Orvieto","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.08.007_bib15","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.fertnstert.2007.08.032","article-title":"Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve","volume":"90","author":"Oriol","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.08.007_bib16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/uog.7344","article-title":"Ultrasound monitoring in patients undergoing in-vitro fertilization after methotrexate treatment for ectopic pregnancy","volume":"34","author":"Provansal","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2013.08.007_bib17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.fertnstert.2008.07.009","article-title":"Effect of methotrexate exposure on subsequent fertility in women undergoing controlled ovarian stimulation","volume":"92","author":"McLaren","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.08.007_bib18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/1097-0142(196003\/04)13:2<236::AID-CNCR2820130205>3.0.CO;2-R","article-title":"Studies on the folic acid vitamins, and the persistence of amethopterin in mammalian tissues","volume":"13","author":"Charache","year":"1960","journal-title":"Cancer"},{"key":"10.1016\/j.fertnstert.2013.08.007_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.reprotox.2008.11.055","article-title":"The safety of conception occurring shortly after methotrexate treatment of an ectopic pregnancy","volume":"27","author":"Svirsky","year":"2009","journal-title":"Reprod Toxicol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502821302952X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502821302952X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:28:08Z","timestamp":1771435688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001502821302952X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S001502821302952X"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2013.08.007","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does methotrexate administration for\u00a0ectopic pregnancy after in\u00a0vitro fertilization impact ovarian reserve or ovarian responsiveness?","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2013.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}